Malin Life Sciences Holdings Limited 13D and 13G filings for Poseida Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-15 4:27 pm Sale | 2025-01-08 | 13G | Poseida Therapeutics, Inc. PSTX | Malin Life Sciences Holdings Limited | 0 0.000% | -9,188,125 (Position Closed) | Filing |
| 2021-02-03 06:15 am Purchase | 2020-07-14 | 13G | Poseida Therapeutics, Inc. PSTX | Malin Life Sciences Holdings Limited | 9,188,125 14.900% | 9,188,125 (New Position) | Filing |